Dose Modification for Safe Treatment of a Compound Complex Heterozygous DPYD Variant Carrier With Fluorouracil

Схожие документы

• Histone H3K27 trimethylation modulates 5-fluorouracil resistance by inhibiting PU.1 binding to the DPYD promoter
  по: Wu, Rentian, et al.
  Опубликовано: (2016)
• Gene-specific variant classifier (DPYD-Varifier) to identify deleterious alleles of dihydropyrimidine dehydrogenase
  по: Shrestha, Shikshya, et al.
  Опубликовано: (2018)
• Quantitative contribution of rs75017182 to dihydropyrimidine dehydrogenase mRNA splicing and enzyme activity
  по: Nie, Qian, et al.
  Опубликовано: (2017)
• Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity
  по: Offer, Steven M., et al.
  Опубликовано: (2013)
• Response to “A case of 5-FU related severe toxicity associated to the p.Y186C DPYD variant”
  по: Offer, Steven M., et al.
  Опубликовано: (2013)